WO2025232837 - MODIFIED SIRNA, AND PREPARATION METHOD THEREFOR AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/232837
Publication Date
13.11.2025
International Application No.
PCT/CN2025/093458
International Filing Date
08.05.2025
Title **
[English]
MODIFIED SIRNA, AND PREPARATION METHOD THEREFOR AND USE THEREOF
[French]
ARNSI MODIFIÉ, PROCÉDÉ DE PRÉPARATION S'Y RAPPORTANT ET UTILISATION ASSOCIÉE
[Chinese]
经修饰的siRNA及其制备方法和用途
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
WU, Junjun
JIANG, Wenjuan
ZHANG, Weiji
LI, Jiani
WEI, Qingzhu
XIAO, Ying
LU, Yinsuo
Priority Data
202410567289.9
08.05.2024
CN
202411848273.1
13.12.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1658 | |
| EPO | Filing, Examination, Granting | 11624 | |
| Japan | Filing, Examination, Granting | 2045 | |
| South Korea | Filing, Examination, Granting | 1887 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,954
Contact Us
Abstract[English]
Provided are a modified siRNA, and a preparation method therefor and a use thereof. The modified siRNA can be used to treat and/or prevent pathological conditions or diseases caused by abnormal gene expression.[French]
L'invention concerne un ARNsi modifié, un procédé de préparation s'y rapportant et une utilisation associée. L'ARNsi modifié peut être utilisé pour traiter et/ou prévenir des affections ou des maladies pathologiques provoquées par une expression génique anormale.[Chinese]
提供一种经修饰的siRNA及其制备方法和用途，该经修饰的siRNA可以治疗和/或预防由基因异常表达引起的病理状况或疾病。